Special Report

Is there any role for physical therapy in chronic GvHD?

• J Mohammed
• B N Savani
• S K Hashmi

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation

• S Corbacioglu
• E Carreras
• P Bader

A review of hematopoietic cell transplantation in China: data and trends during 2008–2016

• L-P Xu
• D-P Wu
• X-J Huang

First experience of hematopoietic stem cell transplantation treatment of Shwachman–Diamond syndrome using unaffected HLA–matched sibling donor produced through preimplantation HLA typing

• A A Isaev
• R V Deev
• B V Afanasyev

JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement

• J A Snowden
• E McGrath
• M Mohty

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

• J R Passweg
• H Baldomero
• M Mohty

The EBMT–ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis

• T Ruutu
• A Gratwohl
• R F Duarte

Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)

• J R Passweg
• H Baldomero
• M Mohty

What is the P-value anyway?

• R P Gale
• M-J Zhang

Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT

• P Tsirigotis
• M Byrne
• A Nagler

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

• M Mohty
• F Malard
• E Carreras

Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury

• N Oliver
• T Luong
• A Abudayyeh

Development, preliminary usability and accuracy testing of the EBMT ‘eGVHD App’ to support GvHD assessment according to NIH criteria—a proof of concept

• H Schoemans
• K Goris
• R F Duarte

Does ex vi vo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

• M C Oliveira
• M Labopin
• D Farge

Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes

• R Peffault de Latour
• C Peters
• J-H Dalle

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

• A Sureda
• P Bader
• A Madrigal

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

• M Mohty
• F Malard
• E Carreras

Related hematopoietic cell donor care: is there a role for unrelated donor registries?

• C Anthias
• S M van Walraven
• B E Shaw

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

• J R Passweg
• H Baldomero
• M Mohty

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

• T Alexander
• A Bondanza
• D Farge